Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
AstraZeneca has bought a second biologics site in Colorado from Amgen. The Longmont facility, reported by local media outlets to have been acquired for $64.5 million, will be used to support operations at the Boulder site that the company bought from Amgen in September 2015. The purchase of the Boulder plant doubled AstraZeneca’s U.S. manufacturing capacity for biologics, which occupy a growing proportion of the company’s drug pipeline. AstraZeneca says it will add staff in Longmont as its pipeline matures.
This article has been sent to the following recipient: